Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

被引：0
|
作者：
Ying-Jun Chang
Yu Wang
Lan-Ping Xu
Xiao-Hui Zhang
Huan Chen
Yu-Hong Chen
Feng-Rong Wang
Yu-Qian Wei-Han
Chen-Hua Sun
Fei-Fei Yan
Xiao-Dong Tang
Yan-Rong Mo
Kai-Yan Liu
Xiao-Jun Liu
机构：
[1] Peking University People’s Hospital & Peking University Institute of Hematology,Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies
[2] National Clinical Research Center for Hematologic Disease,undefined
[3] Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,undefined
[4] Peking-Tsinghua Center for Life Sciences,undefined
[5] Chinese Academy of Medical Sciences,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Haploidentical donor transplantation; Acute lymphoblastic leukemia; Matched sibling donor transplantation; Measurable residual disease; Donor selection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [41] A RANDOMIZED PHASE III TRIAL INVESTIGATING 2 Gy TBI VS. Flu/2 Gy TBI CONDITIONING FOR HLA-MATCHED RELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TEMPO OF CD3 AND NK CELL ENGRAFTMENT DETERMINES RELAPSE AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH HEMATOLOGIC
    Kornblit, B.
    Storer, B.
    Storb, R. F.
    Hari, P.
    Vucinic, V.
    Maziarz, R. T.
    Chauncey, T.
    Pulsipher, M. A.
    Bruno, B.
    Petersen, F. B.
    Bethge, W. A.
    Hubel, K.
    Storek, J.
    Maloney, D. G.
    Sandmaier, B. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S214 - S214
  • [42] Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)
    Tanosaki, Ryuji
    Choi, Ilseung
    Shimokawa, Mototsugu
    Utsunomiya, Atae
    Tokunaga, Masahito
    Nakano, Nobuaki
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Takemoto, Shigeki
    Kusumoto, Shigeru
    Tomoyose, Takeaki
    Sueoka, Eisaburo
    Shiratsuchi, Motoaki
    Suehiro, Youko
    Yamanaka, Takeharu
    Okamura, Jun
    Uike, Naokuni
    BLOOD, 2014, 124 (21)
  • [43] A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial
    Sandmaier, Brenda M.
    Maris, Michael
    Storer, Barry
    Vindelov, Lars
    Langston, Amelia
    Wade, James C.
    Bethge, Wolfgang A.
    Pulsipher, Michael
    Lange, Thoralf
    Chauncey, Thomas
    Petersen, Finn
    Huebel, Kai
    Woolfrey, Ann
    Flowers, Mary E. D.
    Maloney, David G.
    Storb, Rainer F.
    BLOOD, 2009, 114 (22) : 147 - 147
  • [44] Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
    Buhmann, Raymund
    Michael, Stanglmaier
    Juergen, Hess
    Horst, Lindhofer
    Peschel, Christian
    Kolb, Hans-Jochem
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [45] Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
    Raymund Buhmann
    Stanglmaier Michael
    Hess Juergen
    Lindhofer Horst
    Christian Peschel
    Hans-Jochem Kolb
    Journal of Translational Medicine, 11
12345